Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Parent, D. Bachir, F. Lionnet, J. Inamo, L. Savale, F. Driss, G. Loko, S. Bennani, B. Maître, R. Girot, F. Galacteros, G. Simonneau (Clamart, Créteil, Paris, Le Kremlin Bicêtre, France; Fort de France, Le Lamentin, Martinique). Prevalence and mechanism of pulmonary hypertension in sickle cell disease: a prospective multicentre french study. Eur Respir J 2009; 34: Suppl. 53, 170

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary arterial hypertension associated with primary Sjögren's syndrome: a multicentre cohort study from China Source: Eur Respir J, 56 (5) 1902157; 10.1183/13993003.02157-2019 Year: 2020 Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study Source: ERJ Open Res, 8 (1) 00443-2021; 10.1183/23120541.00443-2021 Year: 2022 Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study Source: Eur Respir J, 54 (4) 1900897; 10.1183/13993003.00897-2019 Year: 2019 Prospective study of lung function in children with sickle cell disease Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003 Treatment of severe pulmonary hypertension secondary to chronic lung disease: A multicentre study. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Prevalence of chronic thrombo-embolic pulmonary hypertension after pulmonary embolism: A prospective multicenter study Source: Annual Congress 2010 - Pulmonary hypertension updates Year: 2010 Late Breaking Abstract - COVID-19 in patients with pulmonary hypertension: a national prospective cohort study Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020 Use of bosentan for the treatment of pulmonary arterial hypertension in Spain: a multicenter, retrospective, observational study Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Multi-institutional prospective registry in pulmonary hypertension associated with respiratory disease in Japan. Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Prospective cohort study of the alternate healthy eating index-2010 and risk of chronic obstructive pulmonary disease in US women and men Source: Annual Congress 2013 –Environment and lifestyle: associations with respiratory disease Year: 2013 Pulmonary vascular disease (PVD) in patients with Sjögren syndrome - a prospective cross-sectional study Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside Year: 2019 Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976–2013 Source: Eur Respir J , 49 (2) 1601290; DOI: 10.1183/13993003.01290-2016 Year: 2017 Association between chronic obstructive pulmonary disease and endometriosis: a population-based cohort study Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases Year: 2020 PEGASUS - the effects of commercial air travel on patients suffering from pulmonary hypertension - a prospective, multicenter, multinational study Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Feasibility of home spirometry in patients with chronic graft-versus-host disease: a prospective observational study Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 A multicenter case-control study of genetic risk factors for portopulmonary hypertension (POPH) Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial Source: ERJ Open Res, 5 (3) 00110-2019; 10.1183/23120541.00110-2019 Year: 2019